Finanzen von AxoGen, Inc. (AXGN)AXGNAxoGen, Inc.

Evaluating the bottom line, AxoGen, Inc. maintains a gross margin of 72.67%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -3.09%, while the net margin is -2.17%. These profitability ratios, combined with a Return on Equity (ROE) of -18.21%, provide a clear picture of how effectively AXGN converts its operational activities into shareholder value.

In the context of the broader market, AXGN competes directly with industry leaders such as INSP and TMDX. With a market capitalization of $2.03B, it holds a significant position in the sector. When comparing efficiency, AXGN's gross margin of 72.67% stands against INSP's 85.48% and TMDX's 59.59%. Such benchmarking helps identify whether AxoGen, Inc. is trading at a premium or discount relative to its financial performance.

AxoGen has shown strong revenue growth, with Q2 2026 revenue at $69.73 million, and a gross margin of 72.67%. However, it has faced net income losses recently, with a net income of -1.52 million in Q2 2026.